Description
Cancer is the leading cause of death in Canada, and while immunotherapy shows promise, it faces challenges such as high costs, long production times, and severe side effects. The Maganti laboratory at Canadian Blood Services has developed a…
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02025-05-01$168,856
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2025-05-01(start date) | $168,856 | — | Cancer is the leading cause of death in Canada, and while immunotherapy shows promise, it faces challenges suc… |
Related records · 11
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 870157641)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 033-2025-2026-Q4-515751 | Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada · Life Sciences Fund Contributions | $75,000,000 | FY2026 |
| 271-2025-2026-Q2-00033 | Health Canada | Santé Canada · Organs, Tissues and Blood Program | $31,200,000 | FY2025 |
| 271-2025-2026-Q4-00056 | Health Canada | Santé Canada · Organs, Tissues and Blood Program | $31,600,000 | FY2025 |
| 271-2024-2025-Q2-00028 | Health Canada | Santé Canada · Organs, Tissues and Blood Program | $25,000,000 | FY2025 |
| 271-2024-2025-Q3-00080 | Health Canada | Santé Canada · Organs, Tissues and Blood Program | $26,800,000 | FY2025 |
| 172-2023-2024-Q4-1015395 | National Research Council Canada | Conseil national de recherches Canada · Collaborative Science, Technology and Innovation Program – Ideation Fund | $25,000 | FY2024 |
Other recipients funded under "Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2026-2027-Q1-1044103 | York University | FY2027 | $462,000 | FY2027 |
| 172-2026-2027-Q1-1043787 | Simon Fraser University | FY2027 | $279,766 | FY2027 |
| 172-2026-2027-Q1-1044229 | Noram Electrolysis Systems Inc. | FY2027 | $300,053 | FY2027 |
| 172-2026-2027-Q1-1043305 | University of Ottawa | FY2027 | $418,000 | FY2027 |
| 172-2026-2027-Q1-1043602 | University of Windsor | FY2027 | $99,000 | FY2027 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2025-2026-Q1-1029082 · retrieved 2026-11-12.